[HTML][HTML] Postprandial peaking and plateauing of triglycerides and VLDL in patients with underlying cardiovascular diseases despite treatment
CE Samson, ALB Galia, KIC Llave… - … of endocrinology and …, 2012 - ncbi.nlm.nih.gov
CE Samson, ALB Galia, KIC Llave, MB Zacarias, LB Mercado-Asis
International journal of endocrinology and metabolism, 2012•ncbi.nlm.nih.govBackground Dyslipidemia is associated with cardiovascular morbidities and mortality.
Currently, fasting lipid profile determination is used to monitor treatment response. Recently,
postprandial lipemia is of increasing interest because of its atherogenic and thrombogenic
potential and also was found to be more predictive for cardiovascular diseases. Objectives
To demonstrate postprandial lipemia among patients with cardiovascular diseases despite
low fat diet, normal fasting lipid profile and even statin regimen.
Currently, fasting lipid profile determination is used to monitor treatment response. Recently,
postprandial lipemia is of increasing interest because of its atherogenic and thrombogenic
potential and also was found to be more predictive for cardiovascular diseases. Objectives
To demonstrate postprandial lipemia among patients with cardiovascular diseases despite
low fat diet, normal fasting lipid profile and even statin regimen.
Abstract
Background
Dyslipidemia is associated with cardiovascular morbidities and mortality. Currently, fasting lipid profile determination is used to monitor treatment response. Recently, postprandial lipemia is of increasing interest because of its atherogenic and thrombogenic potential and also was found to be more predictive for cardiovascular diseases.
Objectives
To demonstrate postprandial lipemia among patients with cardiovascular diseases despite low fat diet, normal fasting lipid profile and even statin regimen.
ncbi.nlm.nih.gov